Cargando…
Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke
Cyclooxygenase (COX)-2 and matrix metalloproteinase (MMP)-9 are two crucial mediators contributing to blood-brain barrier (BBB) damage during cerebral ischemia. However, it is not known whether MMP-9 activation is involved in COX-2-mediated BBB disruption in ischemic stroke. In this study, we hypoth...
Autores principales: | Yang, Changjun, Yang, Yi, DeMars, Kelly M., Rosenberg, Gary A., Candelario-Jalil, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468510/ https://www.ncbi.nlm.nih.gov/pubmed/32973660 http://dx.doi.org/10.3389/fneur.2020.00887 |
Ejemplares similares
-
Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic stroke
por: Hawkins, Kimberly E, et al.
Publicado: (2013) -
Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke
por: Frankowski, Jan C., et al.
Publicado: (2015) -
Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke
por: DeMars, Kelly M., et al.
Publicado: (2018) -
Selective Inhibition of Janus Kinase 3 Has No Impact on Infarct Size or Neurobehavioral Outcomes in Permanent Ischemic Stroke in Mice
por: DeMars, Kelly M., et al.
Publicado: (2017) -
Age-Dependent Decrease in Adropin is Associated with Reduced Levels of Endothelial Nitric Oxide Synthase and Increased Oxidative Stress in the Rat Brain
por: Yang, Changjun, et al.
Publicado: (2018)